G9a coordinates with the RPA complex to promote DNA damage repair and cell survival

Qiaoyan Yang1, Qian Zhu1, Xiaopeng Lu1,2

  • 1Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.

Insights

Histone methyltransferase G9a aids cancer cell survival by facilitating DNA repair. Its inhibition impairs DNA damage response, increasing cancer cell sensitivity to therapies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • DNA Repair Mechanisms

Background:

  • Histone methyltransferase G9a (G9a) is known for its roles in cancer cell growth and gene suppression.
  • Its involvement in the DNA damage response (DDR) remains largely unexplored.

Purpose of the Study:

  • To investigate the role of G9a in the DNA damage response and its potential as a therapeutic target in cancer.

Main Methods:

  • Studied the effect of G9a loss on DNA damage repair and sensitivity to genotoxic agents.
  • Investigated G9a phosphorylation, recruitment to chromatin, and interaction with DNA repair proteins like Replication Protein A (RPA) following DNA double-strand breaks (DSBs).
  • Assessed the impact of G9a-RPA interaction on RPA foci formation and homologous recombination (HR).

Main Results:

  • Loss of G9a impairs DNA damage repair and increases cancer cell sensitivity to radiation and chemotherapy.
  • G9a is phosphorylated by casein kinase 2 (CK2) at serine 211 in response to DSBs and recruited to chromatin.
  • Chromatin-bound G9a directly interacts with RPA, promoting RPA and Rad51 loading to DSBs, which facilitates HR and cell survival.

Conclusions:

  • A novel regulatory pathway involving CK2-G9a-RPA in facilitating homologous recombination in cancer cells was identified.
  • G9a plays a critical role in DNA double-strand break repair through homologous recombination.
  • Targeting G9a may represent a viable therapeutic strategy to enhance cancer treatment efficacy.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
5.4K
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
41.2K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K